GTEX-15SHW
|
61-70
|
Male
|
GTEX-15SHW-0826 |
Liver
|
PAXgene |
1
|
2 pieces; congestion, mild fibrosis and inflammation
|
Acceptable
|
|
GTEX-15SKB
|
61-70
|
Male
|
GTEX-15SKB-2126 |
Liver
|
PAXgene |
1
|
2 pieces, moderate congestion
|
Acceptable
|
|
GTEX-15SZO
|
51-60
|
Male
|
GTEX-15SZO-1226 |
Liver
|
PAXgene |
1
|
2 pieces, diffuse macrovesicular steatosis, ~90% parenchymal involvement
|
Acceptable
|
|
GTEX-15TU5
|
51-60
|
Male
|
GTEX-15TU5-2126 |
Liver
|
PAXgene |
1
|
2 pieces; mild central congestion and atrophy
|
Acceptable
|
|
GTEX-15UF6
|
61-70
|
Female
|
GTEX-15UF6-1326 |
Liver
|
PAXgene |
1
|
2 pieces; severe central passive congestion with liver cell degeneration
|
Acceptable
|
|
GTEX-15UF7
|
41-50
|
Male
|
GTEX-15UF7-0426 |
Liver
|
PAXgene |
1
|
2 pieces; includes portion of capsule (target is 1 cm below capsule), portal chronic inflammation, mild steatosis, centrally congested and mildly autolyzed
|
Acceptable
|
|
GTEX-15UKP
|
21-40
|
Male
|
GTEX-15UKP-1026 |
Liver
|
PAXgene |
0
|
2 pieces; 1 piece includes capsule (target is 1 cm below capsule)
|
Acceptable
|
|
GTEX-16GPK
|
61-70
|
Male
|
GTEX-16GPK-1926 |
Liver
|
PAXgene |
2
|
2 pieces; congestion and steatosis
|
Acceptable
|
|
GTEX-16MT8
|
61-70
|
Female
|
GTEX-16MT8-2126 |
Liver
|
PAXgene |
1
|
2 pieces, liver, moderate chronic passive congnestion, early fibrosis noted
|
Acceptable
|
|
GTEX-16MT9
|
61-70
|
Female
|
GTEX-16MT9-2126 |
Liver
|
PAXgene |
2
|
2 pieces; severe congestion; mild steatosis
|
Acceptable
|
|
GTEX-16NPV
|
51-60
|
Female
|
GTEX-16NPV-1726 |
Liver
|
PAXgene |
2
|
2 pieces; nodular cirrhosis
|
Acceptable
|
|
GTEX-16NPX
|
51-60
|
Male
|
GTEX-16NPX-1326 |
Liver
|
PAXgene |
1
|
2 pieces, mild passive congestion
|
Acceptable
|
|
GTEX-16XZZ
|
61-70
|
Male
|
GTEX-16XZZ-1526 |
Liver
|
PAXgene |
1
|
2 pieces; cirrhosis: fibrous scar makes up about 40% of area
|
Acceptable
|
|
GTEX-16YQH
|
21-40
|
Male
|
GTEX-16YQH-1126 |
Liver
|
PAXgene |
1
|
2 pieces, ~5-10% steatosis, macro and microvesicular
|
Acceptable
|
|
GTEX-16Z82
|
61-70
|
Male
|
GTEX-16Z82-1426 |
Liver
|
PAXgene |
1
|
2 pieces; moderate sinusoidal congestion
|
Acceptable
|
|
GTEX-17EVP
|
41-50
|
Male
|
GTEX-17EVP-1026 |
Liver
|
PAXgene |
1
|
2 pieces; moderate congestion and mild macrovesicular steatosis
|
Acceptable
|
|
GTEX-17EVQ
|
61-70
|
Male
|
GTEX-17EVQ-0926 |
Liver
|
PAXgene |
1
|
2 pieces, moderate chronic congestion
|
Acceptable
|
|
GTEX-17F96
|
61-70
|
Male
|
GTEX-17F96-1226 |
Liver
|
PAXgene |
1
|
2 pieces; moderate central vein congestion
|
Acceptable
|
|
GTEX-17F97
|
51-60
|
Male
|
GTEX-17F97-2226 |
Liver
|
PAXgene |
2
|
2 pieces; severe central congestion & atrophy
|
Acceptable
|
|
GTEX-17F9Y
|
61-70
|
Female
|
GTEX-17F9Y-0626 |
Liver
|
PAXgene |
1
|
2 pieces, moderate passive congestion
|
Acceptable
|
|
GTEX-17HG3
|
21-40
|
Female
|
GTEX-17HG3-0526 |
Liver
|
PAXgene |
2
|
2 pieces; congestion
|
Acceptable
|
|
GTEX-17HGU
|
51-60
|
Male
|
GTEX-17HGU-1826 |
Liver
|
PAXgene |
1
|
2 pieces; mild congestion; <5% macrovesicular steatosis
|
Acceptable
|
|
GTEX-17HHE
|
41-50
|
Male
|
GTEX-17HHE-0126 |
Liver
|
PAXgene |
1
|
2 pieces, mild microvesicular steatosis
|
Acceptable
|
|
GTEX-17HHY
|
51-60
|
Male
|
GTEX-17HHY-2026 |
Liver
|
PAXgene |
2
|
2 pieces; prominent central macrovesicular steatosis: 20%
|
Acceptable
|
|
GTEX-17HII
|
51-60
|
Male
|
GTEX-17HII-1026 |
Liver
|
PAXgene |
1
|
2 pieces mild-moderate passive congestion
|
Acceptable
|
|